Fred Alger Management, LLC Agios Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $3.49 Million - $4.48 Million	-48,707 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$73.22 - $99.55 $155,812 - $211,842	-2,128 Reduced 4.19%	48,707 $4.1 Million
Q1 2018 May 10, 2018	BUY	$59.83 - $86.53 $3.04 Million - $4.4 Million	50,835 New	50,835 $4.16 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.99B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.